A Comparison of the Drug Therapy Versus Re-Ablation
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The hypothesis of this study was that early re-ablation (test) was superior to AAD therapy
(control) in patients with previous failed PVI ablation for paroxysmal AF.
Phase:
Phase 2
Details
Lead Sponsor:
Meshalkin Research Institute of Pathology of Circulation